Navigation Links
PTEN: the Treg's handbrake

Naturally occurring CD4+CD25+ Tregs are a specialized subpopulation of T cells that function to prevent other T cells destroying self-tissues. But harnessing the therapeutic potential of Tregs -- for example, to treat autoimmune diseases such as diabetes and rheumatoid arthritis -- is hampered by problems generating sufficient cells to be therapeutically effective. This is because, unlike non-regulatory T cells, Tregs do not proliferate in vitro when stimulated through either their TCR or IL-2 receptor alone.

Now, in a study appearing online on August 17 in advance of print publication in the September issue of the Journal of Clinical Investigation, Laurence Turka and colleagues from the University of Pennsylvania have shown that Tregs from mice with T cells that lack phosphatase and tensin homolog (PTEN) proliferate in response to IL-2. Importantly, PTEN-deficient Tregs retained their suppressive function in vitro and in vivo, indicating that loss of PTEN by Tregs only affects their proliferative capabilities in response to IL-2 and not their other functions. These results identify PTEN as a key protein that regulates the lack of responsiveness of Tregs to IL-2 and could provide researchers with a way to overcome one of the biggest obstacles to harnessing their therapeutic potential.


'"/>

Source:Journal of Clinical Investigation


Page: 1

Related biology news :

1. NHGRI targets 12 more organisms for genome sequencing
2. NHGRI Selects 13 More Organisms for Genome Sequencing
3. NHGRI expands effort to revolutionize sequencing technologies
4. NHGRI announces new sequencing targets
5. NHGRI aims to make DNA sequencing faster, more cost effective
6. Wiley announces publication of Databasing the Brain
7. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
8. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
9. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
10. GlycoFi announces the first production of antibodies with human glycosylation in yeast
11. CHAVI announces international search for genes affecting HIV response
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: PTEN the Treg handbrake

(Date:12/14/2009)... or for Tasmanian devils biting each other ... the dinosaurs to extinction through the transmission of a ... Biology, highlights the ,paleobiological detective work, of David Varricchio ... to deduce that a protozoan parasite was to blame ... fossils. , The parasite,s modern-day equivalent, which infects birds, ...
(Date:12/14/2009)... Scientists once thought of tool use as a defining feature ... from other primates, along with birds and an array of ... of Current Biology , a Cell Press publication, adds ... The veined octopus under study manages a behavioral trick that ... spreads itself over stacked, upright coconut shell "bowls," makes its ...
(Date:12/13/2009)... have resolved a question about how a popular ... using biosensors that reveal previously hidden components of ... delusions and hallucinations characterize the illness, people with ... information in a particular order, difficulties that interfere ... function well, said Lee Schroeder, a student in ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 1Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 3Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 4July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook Bells Palsy and Heart Valve Repair 4765 1July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook Bells Palsy and Heart Valve Repair 4765 2July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook Bells Palsy and Heart Valve Repair 4765 3July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook Bells Palsy and Heart Valve Repair 4765 4July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook Bells Palsy and Heart Valve Repair 4765 5HIV Drugs Provide Breast Fed Babies With Some Protection 52425 1HIV Drugs Provide Breast Fed Babies With Some Protection 52425 2
... University of Montana, University of California - Santa Cruz, ... that a top predator strongly affected plants and animals ... eating organisms that transport nutrients between ecosystems. "An ... nutrient subsidies," is published in the February issue of ...
... Liver transplant patients with hepatitis C virus (HCV) ... the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination ... virus in vitro. , The results of ... of Liver Transplantation, the official journal of the ...
... Clinic research team has challenged the accepted theory on ... the body's cells generate fever, shock and often death. ... infection interfere with the cells. , The Mayo researchers ... an opinion piece in the current issue of Trends ...
Other Biology News:Not just the birds 2Not just the birds 3Cyclosporine inhibits hepatitis C virus in vitro 2Mayo Clinic researchers challenge sepsis theory 2Mayo Clinic researchers challenge sepsis theory 3
(Date:12/14/2009)... with State Biotech Leaders to Develop Blueprint ... Development while Boosting Rhode Island,s Growing Biotech ... R.I., Dec. 14 Several of ... medicine and biotechnology gathered today at Brown ... importance of medical innovation in Rhode Island ...
(Date:12/14/2009)... 14 Lionbridge (Nasdaq: LIOX ... a new, three-year master services agreement with ... and services that serve patients in approximately ... become the sole provider for translation of ... marketing, training, human resources, legal, and corporate ...
(Date:12/14/2009)... a US-based thermoforming company, has completed the delivery of Brookfield ... metal to a plastic enclosure with a smaller footprint and ... ... MA (PRWEB) December 14, 2009 -- ThermoFab, a US-based thermoforming ... Tester – helping Brookfield move from sheet metal to a ...
(Date:12/11/2009)... 11 Dendreon Corporation (Nasdaq: DNDN ... previously announced public offering have exercised in full ... of common stock at the public offering price ... the option increases the size of the offering ... stock. Dendreon expects to receive net proceeds ...
Breaking Biology Technology:Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... Financial Highlights ($ in millions, except per share data), Item ... Total BioMarin Revenue $296.5 143.9% increase, ... $132.7 53.9% increase, Aldurazyme Net Sales by, ... 22.3% increase, Aldurazyme BioMarin Net, Product Revenue ...
... Corp., a,biopharmaceutical company developing dermatological products, anti-infective,treatments and intranasal ... series B equity financing with Perseus LLC and other ... been directed toward the,development of the company,s NanoStat(TM) technology ... funding will be used by the company to complete ...
... Board of Directors wishes to confirm to Stockholders that at ... a Form 15 with effect from February 17, 2009. ... in the interests of keeping stockholders and other stakeholders informed ... is to release the company from its United States Securities ...
Other Biology Technology:BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 2BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 3BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 4BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 5BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 6BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 7BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 8BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 9BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 10BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 11BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 12BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results 13NanoBio Corporation Raises $12 Million in Series B Financing 2EESTECH Inc - Release From SEC Filing 2EESTECH Inc - Release From SEC Filing 3EESTECH Inc - Release From SEC Filing 4
Adhesion Molecule Antibodies...
Goat polyclonal to Factor VIII, prediluted ( Abpromise for all tested applications). Antigen: Full length native protein (purified) (Human): Factor VIII from blood. Entrez GeneID: 2157 Sw...
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
... Timp-4 has been reported in ... some fibroblasts in cell culture conditions. ... ester TPA stimulates production of TIMP-4 ... low protein levels produced often require ...
Biology Products: